Want to join the conversation?
$STX 3Q15 10-Q: STX’s authorized share capital is $13,500 and consists of 1,250,000,000 ordinary shares, par value $0.00001, of which 318,076,549 shares were outstanding as of April 3, 2015, and 100,000,000 preferred shares, par value $0.00001, of which none were issued or outstanding as of April 3, 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.